Top

News & Events

Client News

Client News Our News Insights Features

24 December 2015
Avita Medical sells Respiratory Business for $2.64m

17 December 2015
Abcodia’s ROCA Test® used in UKCTOCS trial; data shows ovarian cancer screening could reduce mortality by 20%

17 December 2015
Ablynx Completes Enrolment Of The First-In-Infant Phase I/IIa Safety Study With Its Anti-RSV Nanobody And Extends The Trial For Younger Infants

17 December 2015
Dimerix Limited announces appointment of Dr Liz Jazwinska as Non-Executive Director

16 December 2015
William (Bill) Hunter MD to Join Adherium Board

16 December 2015
NetScientific appoints diagnostics leader Lawrence Cohen as CEO of Glycotest Inc.

15 December 2015
Dutch VC Aglaia BioMedical Ventures invests in Swiss biotech Inthera Bioscience

14 December 2015
Avita Medical: FDA Grants ReCell Expedited Access Pathway Designation

14 December 2015
NETSCIENTIFIC: Ex Novartis Diagnostics president, Gene Walther is appointed CEO of Vortex BioSciences and NetScientific’s Head of Diagnostics

14 December 2015
Premaitha Health signs Investment Agreement with Thermo Fisher Scientific

14 December 2015
Premaitha Health plc: Results for the half year ended 30 September 2015

14 December 2015
Dimerix Limited receives Orphan Designation for its lead drug candidate targeting patients with chronic kidney disease

14 December 2015
SEVENTURE: A Major Pharmaceutical Company participates as Strategic investor in Health for Life Capital™ the first investment vehicle focused on the microbiome health and nutrition revolutionary sector

10 December 2015
ImmBio Initiates First-in-Human Studies of its Novel Pneumococcal Vaccine, PnuBioVax

10 December 2015
Karus Therapeutics Announces Strategic Collaboration with The University of Texas MD Anderson Cancer Center

10 December 2015
Oxford Gene Technology Announces Commercial and Financial Highlights for FY 2015

09 December 2015
Avita Medical Highlights Report of 63% Decreased Length of Hospital Stay for Patients with Large Burns treated using ReCell®

05 December 2015
ADC Therapeutics Announces Positive Pre-clinical Results for Two of its Novel ADCs at the American Society of Hematology Conference

04 December 2015
DNAe Expands US Operations with Clinical Diagnostic Development and Manufacturing Site in San Diego

04 December 2015
ADC Therapeutics Receives FDA Clearance to Begin Clinical Studies for its Second Novel Antibody Drug Conjugate ADCT-402 against Lymphomas and Leukemia

03 December 2015
GE Healthcare Life Sciences strengthens business resilience with ISO 22301 business continuity accreditation for chromatography media

03 December 2015
Clinigen Group Partners with Sunesis to Initiate a Compassionate Use Program for Patients with Relapsed or Refractory Acute Myeloid Leukemia

03 December 2015
ProAxsis' ProteaseTag™ technology shown to effectively monitor patients with chronic obstructive pulmonary disease

02 December 2015
Histide Announces Publication in Nature Materials Revealing Mechanisms Governing Stem Cell Differentiation

02 December 2015
Abcodia Announces Initial U.S. Availability of the ROCA® Test to Aid in the Early Detection of Ovarian Cancer

02 December 2015
Premaitha establishes the first IONA® testing service in France at LaboSud

02 December 2015
Innovations portfolio company Kesios Therapeutics raises £19 million in Series A funding round

02 December 2015
Auspherix Appoints Dr. Neil Miller as Chief Scientific Officer

02 December 2015
GHO Capital acquires Quotient Clinical

30 November 2015
Clinigen Group Initiates Managed Access Program for Ixazomib for Patients with Multiple Myeloma

30 November 2015
ProAxsis presents new data to validate its ProteaseTag™ Active NE Immunoassay in chronic obstructive pulmonary disease patients

30 November 2015
Ablynx appoints Robert K. Zeldin, MD, Chief Medical Officer

25 November 2015
Xellia Pharmaceuticals Expands US Production with Acquisition of Manufacturing Plant from Hikma Pharmaceuticals

25 November 2015
Ablynx Announces Nanobody Drug Discovery Collaboration with Novo Nordisk

24 November 2015
Avita Medical Expands Commercial Reach for ReCell® in Wound Care Market with the Appointment of Distributors in France and the UK

24 November 2015
Abcodia Appoints Richard A. Sandberg to its Board of Directors

24 November 2015
Autifony Therapeutics initiates Phase I study of AUT00206, a novel treatment approach for schizophrenia

24 November 2015
Clinigen Group extends exclusive clinical trial distribution agreement with Accord Healthcare for another two years

24 November 2015
Abzena plc: Half year results: Delivery, acquisition and growth

24 November 2015
Abzena plc: Placing to raise £20 million and acquisition

19 November 2015
AmpliPhi Signs Clinical Trial Agreement with University of Adelaide to Conduct a Phase I Trial of Bacteriophage Therapy for Treating Staphylococcus aureus Infections

19 November 2015
EP Vantage: PD-1/PD-L1 Combinations Drive the Development of New Immunotherapies

19 November 2015
Spiral laminar flow is the predominant flow pattern in 97% of volunteers in observational study

19 November 2015
Mucosis Presents Insights on Development of a Novel Needle-Free Vaccine for RSV Prevention at RSV Vaccines for World

18 November 2015
Avita Medical Ltd. Receives Australian Patent

18 November 2015
Ablynx provides business update for the first nine months of 2015

17 November 2015
Crescendo Biologics Appoints Dr Kevin Johnson as Chairman

16 November 2015
GE Healthcare Life Sciences and Emerson team up to drive biopharma manufacturing efficiency

16 November 2015
ADC Therapeutics to Present Data on ADCT-301 and ADCT-402 at American Society of Hematology Annual Meeting

16 November 2015
Nanobiotix revenue for Q3 2015

13 November 2015
Nanobiotix’s Soft Tissue Sarcoma pivotal trial progressing well as planned: already 7 countries and 29 sites opened

12 November 2015
Independent, multi-centre clinical study of the IONA® test in high risk pregnancies shows 100% detection of trisomies and 0% false positives

11 November 2015
Abcam acquires AxioMx to access new growth opportunities and extend antibody leadership

10 November 2015
AmpliPhi Announces Board Expansion with Appointment of Two Highly-Experienced Non-Executive Directors

10 November 2015
Abzena plc: Appointment of Campbell Bunce as Senior Vice President, Scientific Operations

06 November 2015
Avita Medical to Present at ARM’s 2015 EU Advanced Therapies Investor Day

06 November 2015
NetScientific: Result of Placing and Further Allotment of New Shares Pursuant to Offer

05 November 2015
Ablynx’s partner Boehringer Ingelheim presented positive in vivo proof-of-mechanism data with bi-specific nanobody at Euro Global Summit on Cancer Therapy

04 November 2015
Clinigen Group and United Therapeutics Initiate Managed Access Program for UNITUXIN™ (Dinutuximab) Injection for High Risk Neuroblastoma

03 November 2015
Review of haemodynamics in stent development shows spiral flow may be key to improving peripheral arterial stent performance

02 November 2015
DNAe Secures £25 million ($38 million) Bank Facility to Fund Development of Pioneering Point-of-Need IVD for Serious Blood Infections

30 October 2015
Clinigen Group plc: Completion of Acquisition of Link

30 October 2015
Clinigen Group plc: Board appointment

29 October 2015
Sun Biomedical’s Technology Recognised in Leading Peer Review Publication

29 October 2015
e-Therapeutics: Appointment of Non-Executive Director

28 October 2015
Premaitha Health Plc Appointment to the Board

27 October 2015
Avita Medical Presents Research Demonstrating Treatment Power of ReCell® in Burns

27 October 2015
AGM Statement

26 October 2015
Sun Biomedical Limited Expands Kidney Disease Study Sites

22 October 2015
Vascular Flow Technologies launches Spiral Flow™ PV Bypass Graft registry in Germany

22 October 2015
Avita Medical Announces First Patient Treated in US Military Wound Trial

21 October 2015
Puridify completes Series A funding for commercialisation of single-use nanofibre-based purification technology

15 October 2015
Ablynx Achieves First Milestone In Immuno-Oncology Collaboration With Merck & Co., Inc.

14 October 2015
Near doubling of investment rate and gains in unquoted portfolio drive net portfolio value up by £75.2 million to £327.2 million

14 October 2015
Crescendo Biologics Launches New Strategy in Oncology Drug Discovery & Development

14 October 2015
Premaitha opens dedicated clinical laboratory with expanded capacity to meet demand for IONA® test service

13 October 2015
GHO Capital announces acquisition of DNA Diagnostics Center

13 October 2015
Premaitha Health PLC AGM Statement

13 October 2015
In-house Antenatal reflex DNA screening for Down’s syndrome, trisomy 18 and trisomy 13: a world first

12 October 2015
Premaitha: Independent performance study of the IONA® test published

09 October 2015
Adheron Therapeutics is acquired by Roche for its therapeutic antibody

07 October 2015
TranScrip strengthens its Board

02 October 2015
National Institute of Health Research Clinical Research Network Adopts Spiral Flow™ AV Graft Randomised Controlled Trial

02 October 2015
Premaitha appoints Antisel SA to distribute the IONA® test in Greece

01 October 2015
Premaitha Health: Illumina Patent Infringement Proceedings Update

01 October 2015
Australian Biopharmaceutical Company, Paranta Biosciences, Raises AUD$7 million and Starts First Human Clinical Trial of Promising New Therapeutic for Cystic Fibrosis

01 October 2015
NetScientific: Proposed Placing to raise approximately £18.0 million

01 October 2015
NetScientific: Half Year Results for the six months ended 30 June 2015

30 September 2015
New Independent Data on Adherium Smartinhaler™ Clinical Outcomes Shows Increased Adherence and Reduction in Severe Attacks

29 September 2015
Discovery Platform Exceeding Expectations; Company Focus Now on Commercialisation

29 September 2015
Ablynx Initiates a Multinational Phase III Study with Caplacizumab in Patients with Acquired TTP, a Rare Blood Clotting Disorder

25 September 2015
New Independent Data on Adherium Smartinhaler Clinical Outcomes in Paediatric Asthma to be Presented at European Respiratory Congress

22 September 2015
Clinigen to acquire Link Healthcare to strengthen position across Asia, Africa and Australasia

22 September 2015
Premaitha signs first non-European partnership with Servicios Genéticos OriGen to provide the IONA® test for pregnant women in Chile

22 September 2015
Results for the financial year ended 31 March 2015

22 September 2015
Clinigen Group: Great Strides Made in Strategic Priorities, with Underlying EBITDA up 20%

21 September 2015
Clinigen Group and Neuraltus Pharmaceuticals Announce Partnership to Initiate a Managed Access Program for Investigational ALS Therapy in Europe

18 September 2015
AmpliPhi Announces Data Demonstrating Efficacy of a Novel Bacteriophage Cocktail is Comparable to Vancomycin in S. aureus Lung Infection Model

18 September 2015
Abcam appoints Mara Aspinall as Non-Executive Director

17 September 2015
Clinigen Group signs strategic alliance with Cumberland Pharmaceuticals

16 September 2015
Amgen acquires Forbion portfolio company Dezima Pharma

15 September 2015
Auspherix and Domainex Expand Collaboration to Develop New Drugs that Tackle Antibiotic-Resistant Bacterial Infections

14 September 2015
Sun Biomedical (ASX: SBN) Initiates Phase II Clinical Trial of Promising Combination Therapy for Chronic Kidney Disease

10 September 2015
Forbion announces the closing of FCF II Co-invest Fund I at EUR 75M

09 September 2015
Abcam raises antibody validation standards to improve quality for life science researchers

08 September 2015
AmpliPhi Biosciences to Present at Rodman & Renshaw 17th Annual Global Investment Conference

08 September 2015
Forbion invests in Sanifit’s €36.6M ($41M) Series C financing round

03 September 2015
Oxford Gene Technology focuses on high growth genomics products Cytocell®, CytoSure™, and SureSeq™

03 September 2015
Dr John Hutchison joins Autifony Therapeutics as Chief Medical Officer

02 September 2015
AmpliPhi Biosciences Announces Appointment of Alexander Gaidamaka as Vice President of Chemistry, Manufacturing and Control

02 September 2015
ADC Therapeutics Secures $80m Financing to Progress its Pipeline of Antibody Drug Conjugate Therapeutics in Oncology

01 September 2015
Sartorius Stedim Biotech and GE Healthcare sign worldwide OEM supply agreement

01 September 2015
coramaze technologies raises EUR 4.5 million to advance novel transfemoral mitral valve repair system into the clinic

31 August 2015
Forbion Announces - Bristol-Myers Squibb Enters Agreement Providing Exclusive Right to Acquire Promedior, Inc. and its Novel PRM-151 in Development for Fibrotic Diseases

27 August 2015
Nanobiotix Half Year Results For The SIX Months Ended 30 June 2015, In Line With Expectations

27 August 2015
Ablynx Announces Half-Year Results for 2015

20 August 2015
Big Changes for Medtech in First Half of 2015 While Pharma Set To Break Records

18 August 2015
AmpliPhi Biosciences Announces Approval of Common Stock Listing on NYSE MKT

17 August 2015
Half year trading and commercial strategy update

13 August 2015
AmpliPhi Reports Second Quarter 2015 Financial Results and Provides Corporate Update

13 August 2015
Xellia Pharmaceuticals Expands Raleigh, NC Site to Become New North American Headquarters

07 August 2015
NetScientific divests non-core assets to align its healthcare portfolio

05 August 2015
AmpliPhi to Present at the 21st Biennial Evergreen International Phage Meeting

04 August 2015
AmpliPhi BioSciences Cleared to Submit Listing Application to NYSE MKT

04 August 2015
Innovations leads £2.5m funding round in Oxford Biotrans

04 August 2015
ProAxsis launches first-in-class ProteaseTag test for Cystic Fibrosis and Chronic Obstructive Pulmonary Disease

04 August 2015
OGT expands Next Generation Sequencing portfolio

04 August 2015
Ablynx initiates Phase II SLE study with its Anti-IL-6R nanobody, partnered with Abbvie

30 July 2015
AmpliPhi to Present Research on Efficacy of a Novel Bacteriophage Cocktail in S. aureus Lung Infection Model at ICAAC/ICC 2015

30 July 2015
European Technology Platform for Nanomedicine and ENATRANS European Consortium Launch the 2nd edition of the Nanomedicine Award

23 July 2015
Adherium & AstraZeneca Partner to Improve the Lives of Individuals with Respiratory Disease

22 July 2015
Auspherix Expands Board of Directors and Scientific Advisory Board

22 July 2015
LEUKOCARE receives growth capital funding by LifeCare Partners and strengthens its board with industry experts

22 July 2015
Clinigen Group plc: Year end trading update

21 July 2015
Ablynx significantly expands its immuno-oncology collaboration with Merck & Co., inc.

15 July 2015
Nanobiotix revenue for Q2 2015

14 July 2015
NOXXON appoints Aram Mangasarian as CEO

10 July 2015
Autifony Therapeutics extends Series A with £8 million for hearing disorders and schizophrenia clinical trials

09 July 2015
Seventure Partners invests EUR 2 Million Series A in CRISPR-based, microbiome company, Eligo Bioscience

07 July 2015
Clinigen Group Awarded ServiceMark for Consistent World-Class Customer Service

07 July 2015
Vascular Flow Technologies expands global patent landscape with three new patents in Japan, China and Europe

06 July 2015
Premaitha Health receives CQC accreditation for new NIPT clinical service laboratory to support IONA® test customers

02 July 2015
Premaitha Health: Completion of placing to raise £8 million

02 July 2015
Imperial Innovations: Innovations leads £4.0m funding round in Impression Technologies

02 July 2015
Premaitha Health: Proposed placing to raise approximately £8 million

01 July 2015
Nanobiotix starts Phase I/II clinical trial in liver Metastasis and Hepatocellular Cancer with its lead product NBTXR3

01 July 2015
Molecular diagnostics specialist GNA Biosolutions completes EUR 6 million (USD 6.7m) financing round

01 July 2015
Imperial Innovations: First subject enrolled in Veryan Medical’s MIMICS-2 study

30 June 2015
Imperial Innovations leads GBP3 million investment in Abingdon Health

29 June 2015
CytoTools announces positive intermediate results for the European ulcus cruris trial – seamless transition into an approval-relevant phase III trial with less number of patients

24 June 2015
New IONA® test clinical data showcased at the World Congress in Fetal Medicine

22 June 2015
Seventure Partners Appoint Two New Members to its Health for Life Capital Fund Investment Committee

22 June 2015
ADC Therapeutics Appoints Dr. Chris Martin as Chief Executive Officer

22 June 2015
Premaitha Health partners with This Is My to offer non-invasive Down’s syndrome screening blood test

22 June 2015
NetScientific plc Annual General Meeting

19 June 2015
Trading update

18 June 2015
Oxford Gene Technology launches comprehensive SureSeq Myeloid Panel for accurate characterisation of myeloid disorders

17 June 2015
CytoTools AG and existing shareholders strengthen successful subsidiary DermaTools Biotech GmbH with capital increase

17 June 2015
Vascular Flow Technologies announces collaboration with the Society for Vascular Surgery® (SVS) Patient Safety Organization (PSO) to conduct a new post market observational registry of Spiral Laminar Flow™ AV graft for use in haemodialysis access

17 June 2015
MOF Technologies presents improved natural gas storage data at major industry conference, L-NGV

16 June 2015
Evaluate Ltd.: Pharma R&D Pipeline Value Jumps 18 Percent to $493 Billion, Drug Sales Forecast to Grow Nearly Five Percent Annually

16 June 2015
Marks & Clerk: Antibiotics research risks another lost decade while rare diseases research steams ahead, global patent study reveals

16 June 2015
Global Bioenergies: Invest Securities Initiates ALGBE Stock Research Coverage With A Buy Recommendation

15 June 2015
Clinical and performance data from the IONA® test to be presented at the World Congress in Fetal Medicine, Crete

11 June 2015
New 1.4 Million Euro Financing for Global Bioenergies

11 June 2015
e-Therapeutics: Annual General Meeting

09 June 2015
Nanobiotix reports positive preliminary results in Head and Neck cancer Phase I/II clinical trial with NBTXR3

09 June 2015
Clinical Network Services (CNS) voted Australia’s Favourite CRO 2015

09 June 2015
WISE S.r.l. raises EUR 3 million for clinical development of novel neuromodulation implants for spinal cord stimulation

08 June 2015
AmpliPhi to Present New Data on Biological Activity of Nebulized Anti-Pseudomonal Bacteriophage

04 June 2015
Premaitha Health: Directorate Change

03 June 2015
AmpliPhi’s Bacteriophage Manufacturing Facility Receives cGMP Certification

03 June 2015
Dezima Pharma’s CETP Inhibitor, TA-8995, Phase 2b (TULIP) Study Results Published in The Lancet

03 June 2015
Innovations leads £6m Series A funding round in Auspherix

03 June 2015
Auspherix Raises £6Million to Progress its Novel Antibiotics and Establishes UK Operations

02 June 2015
Evaluate Ltd and AdverseEvents, Inc. Team Up to Create New Insight on FDA Adverse Event Reporting

29 May 2015
First Data from NOXXON’s NOX-H94 (Lexaptepid Pegol) Clinical Trial in ESA-Hyporesponsive Dialysis Patients Reported at ERA-EDTA Conference

28 May 2015
Clinigen Group Named Business of the Year at the European Business Awards

28 May 2015
PDS Biotechnology reports positive Phase I clinical trial results in proprietary HPV-Cancer Immunotherapy

28 May 2015
Clinigen Group Appointed as Specialist Partner to Manage Global Access Program for Clovis Oncology’s Rociletinib for the Treatment of EGFR Mutant Non-Small Cell Lung Cancer

27 May 2015
DNAe Chairman Professor Chris Toumazou Awarded IEEE Field Medal in Biomedical Engineering for Outstanding Contributions to Biomedical Circuit Technology

21 May 2015
Cristal Union and Global Bioenergies have formed a joint venture to build and operate France’s first bio-sourced isobutene production plant

21 May 2015
e-Therapeutics: Progress in ETS2101 Phase Ib Study

19 May 2015
AmpliPhi Provides Corporate Update and Reports First Quarter 2015 Financial Results

19 May 2015
Mucosis to Present Data on Intranasal RSV Vaccine SynGEM at Modern Vaccines Adjuvants & Delivery Systems 2015

19 May 2015
Imperial Innovations leads GBP25m Series C funding round in PsiOxus

18 May 2015
Clinigen Group and Pharming Initiate “HAEi GAP” Global Access Program for RUCONEST®

18 May 2015
OccuRx launched with up to AU$6.5 M in funding

18 May 2015
Global Bioenergies: First Renewable Gasoline Sample Delivered to Audi

14 May 2015
TopiVert starts Phase I Clinical Trial in Ulcerative Colitis

12 May 2015
Forbion invests in Autonomic Technologies Europe GmbH

12 May 2015
Global Bioenergies: First Production of Liquid Hydrocarbons from Biological Feedstock Using the Isobutene Process

11 May 2015
Nanobiotix expands Soft Tissue Sarcoma pivotal clinical trial across Europe and beyond, according to plan

11 May 2015
NetScientific appoints Dr François R. Martelet as Chief Executive Officer

07 May 2015
NetScientific invests in wearable digital health company, Neumitra

05 May 2015
Global Bioenergies: First Batch of Isobutene from Renewable Resources Delivered to Arkema

05 May 2015
Themis Bioscience’s Raises up to EUR 10 Million in Series B

05 May 2015
Premaitha files robust defence with UK’s High Court in response to alleged infringement of NIPT patents

01 May 2015
AmpliPhi Biosciences Announces M. Scott Salka as New CEO

01 May 2015
NetScientific forms digital health company with US hospital group, Meridian Health

28 April 2015
Synthon Announces Successful Outcomes from the Open-label extension of the Phase III GATE Study of Synthon’s Glatiramer Acetate

28 April 2015
Global Bioenergies Receives the Tech40 Label From Alternext

27 April 2015
Imperial Innovations - Autifony Therapeutics recruits first patient into Phase IIa trial for age related hearing loss

27 April 2015
Autifony Therapeutics recruits first patient into Phase IIa trial for first-in-class drug to treat Age Related Hearing Loss

24 April 2015
Clinigen: £225 million Acquisition of Idis and £135 million Vendor Placing

23 April 2015
NOXXON Pharma: Nature Communications Publications on the First X-ray Crystal Structures of Spiegelmers Bound to Protein Targets

23 April 2015
Intercept Announces New FLINT Trial Data Showing OCA Treatment Increases Fibrosis Resolution and Cirrhosis Prevention in High-Risk NASH Patients

20 April 2015
Brandon Capital Partners Raises AUD200M New MRCF Fund

20 April 2015
Regenerys® announces pilot study of its Adiposet Service for lipomodelling that will provide safety, confidence and affordability

20 April 2015
MISSION Therapeutics presents at the annual meeting of American Association for Cancer Research (AACR) the identification of novel inhibitors of the UCHL1 oncogene

16 April 2015
Global Bioenergies: Baader Bank Initiates ALGBE Stock Research Coverage with a Buy Recommendation

16 April 2015
Vascular Flow Technologies: Spiral Flow™ AV graft shows substantial improvement in patency over current standard of care

16 April 2015
Autifony Therapeutics announces £3.3 million collaboration to progress first-in-class drug for schizophrenia into clinical trials

15 April 2015
Driving Sustainable Agriculture through Improved Qualities in Eucalyptus and Poplar Trees

15 April 2015
CytoTools AG: Recruitment of patients now complete for European studies on diabetic foot (DFU) and ulcus cruris (VLU) indications

15 April 2015
Nanobiotix: 2014 Annual Results

14 April 2015
Rentschler Biotechnologie expands European manufacturing capabilities with GE Healthcare Life Sciences bioprocess technologies

10 April 2015
FuturaGene’s eucalyptus is approved for commercial use in Brazil

09 April 2015
GLOBAL BIOENERGIES REPORTS 2014 FINANCIAL RESULTS

07 April 2015
Clinigen Group Recognized for Service and Commitment to People Development

01 April 2015
Clinigen Group - Succession Planning - Board Change

01 April 2015
Oxford Gene Technology signs license with Wellcome Trust Sanger Institute for access to Deciphering Developmental Disorders data

31 March 2015
AmpliPhi Granted European Patent for Bacteriophage Therapy to Fight Biofilm-related Bacterial Infections

31 March 2015
PREMAITHA HEALTH: Centrum Badan DNA partners with Premaitha Health to offer the IONA test in Poland

31 March 2015
E-THERAPEUTICS PLC: Four Clinical Trials and Striking Results from Discovery Engine

30 March 2015
DySIS Colposcopy named within UK National Colposcopy Guidelines by the NHS Cervical Screening Programme

30 March 2015
Alesi Surgical secures £2.1m funding to drive commercialisation of Ultravision

27 March 2015
Strong underlying performance and progress across maturing portfolio

25 March 2015
Mucosis to Present on Intranasal Respiratory Syncytial Virus Vaccine Candidate SynGEM® at BioCapital Europe

24 March 2015
NetScientific Full Year results: Significant Progress in Core Portfolio Companies Wanda Health and Vortex BioSciences

23 March 2015
Leading London NHS trust teams up with Premaitha Health to create the UK’s first Centre of Excellence for non-invasive prenatal screening

19 March 2015
Pharma and Biotech M&A Deals Reached Record $212 Billion in 2014

19 March 2015
Next Closing Brings Seventure Partners’ Health for Life Capital Investment Vehicle to €100m

18 March 2015
Imperial Innovations' Cell Medica granted Orphan Drug designation for novel cellular therapy and treats first lymphoma patient in CITADEL Phase II trial

18 March 2015
Cell Medica granted Orphan Drug designation for novel cellular therapy; Treats first lymphoma patient in Phase II trial

18 March 2015
Nanobiotix appoints its Manufacturing Partner, CordenPharma : another step towards commercialization

17 March 2015
Polyphor appoints Michael Altorfer as new CEO and strengthens executive management team

16 March 2015
Premaitha Health: Notice of Patent Infringement Proceedings

16 March 2015
ADC Therapeutics Submits its First IND For a Novel Antibody Drug Conjugate Against Lymphomas

16 March 2015
MISSION Appoints Paul Wallace as Chief Business Officer

16 March 2015
Premaitha Health and Esperite NV Sign a Collaboration Agreement for NIPT Provision in Europe

11 March 2015
AmpliPhi BioSciences Corporation Announces $13 Million Financing

11 March 2015
Oxford Gene Technology Awarded £1.2m Genomics England Contract

11 March 2015
Clinigen Group Extends Exclusive Foscavir® US Distribution Agreement with Hospira to 2019

10 March 2015
Evaluate Ltd.: Five Year Peak Sales Forecast of Newly Reimbursed Drugs in Japan Surges to $34bn

10 March 2015
e-Therapeutics plc: Notification of Full Year Results Date

05 March 2015
SynAffix BV to Present Latest Advancement in Antibody--Drug Conjugate Technology at the 9th Annual BIO Europe Spring Conference in Paris

04 March 2015
Vascular Flow Technologies signs deal with Vascutek to strengthen presence in Europe

03 March 2015
GLOBAL BIOENERGIES reports first isobutene production from waste biomass

03 March 2015
Half year revenues up 17% to £72.6m, underlying EBITDA up 8% to £13.5m

02 March 2015
Themis Bioscience’s Chikungunya Vaccine Study Results Published in The Lancet Infectious Diseases

27 February 2015
Nanobiotix 2014 Q4 and annual revenues

27 February 2015
Clinigen Group Signs Distribution Agreement with MSD UK for Clinical Trial Supply Services

26 February 2015
NetScientific: Appointment to the Board

25 February 2015
Orca Pharmaceuticals and AstraZeneca Announce Development Partnership to Identify Best-in-Class RORy Inhibitors to Treat Autoimmune Disease

20 February 2015
Intercept Announces Promotion of Lisa Bright to Chief Commercial & Corporate Affairs Officer

20 February 2015
Professor Robert Langer joins Nanobiotix as Scientific Advisor

19 February 2015
GNA Biosolutions Leads Consortium for Ultra-Fast Detection of Ebola

19 February 2015
Cell Medica begins commercial production at newly licensed cell therapy manufacturing facility in Germany

19 February 2015
Imperial Innovation's Cell Medica announces start of commercial cell therapy manufacture

18 February 2015
Clinigen Group Adds New Named Patient Program to Global Access Portfolio

16 February 2015
Clinigen: Notification of Half Year Results Date

11 February 2015
MerLion announces FDA approval of finafloxacin otic suspension

11 February 2015
Clinigen Appointed by AstraZeneca to Manage International Global Access Program for New Combination Antibiotic, CAZ-AVI

10 February 2015
Vaxxas Raises AUD 25 Million (USD 20 Million) in Series B Financing to Accelerate Commercialization of Novel Vaccine Platform

05 February 2015
Premaitha Health Launches the IONA® test, the First Ever CE-marked NIPT Product for Pregnant Women

04 February 2015
GLOBAL BIOENERGIES: First milestone hit in BioMA+ project

04 February 2015
Vascular Flow Technologies announces strengthening of US team with the appointment of Dr Barbara Bunger as Chief Clinical Officer

30 January 2015
Premaitha Health Receives ISO 13485:2003 Certification and Meets Annex IV of the In Vitro Diagnostic Medical Device Directive

26 January 2015
Forbion Capital Partners leads CAD 13.5 Million (EUR 9.6 million) Series B financing round for enGene Inc.

22 January 2015
Not for the Faint of CAR-T: The CAR-T Therapy Landscape in 2015

20 January 2015
Vascular Flow Technologies announces new Haemodialysis Access study funded by Scottish Enterprise Grant

19 January 2015
DNAe Acquires nanoMR Inc. in a Strategic Move to Own Complete Workflow for Point-Of-Need NGS-Based Blood-To-Result Diagnostic

19 January 2015
NovaBiotics Raises £5.0 million in a Private Placement from Woodford Investment Management

15 January 2015
Imperial Innovations leads £18 million Series B funding round in Veryan

15 January 2015
Solvanix launched with start-up investment from the MRCF

15 January 2015
Clinigen Group: Half Year Trading Update

14 January 2015
Prosensa Announces Shareholder Approval of Certain Matters Relating to the BioMarin Tender Offer

13 January 2015
Intercept Provides 2014 Year-End Update and Planned 2015 Milestones

09 January 2015
MISSION appoints Anker Lundemose as Chief Executive Officer

09 January 2015
Seventure Invests EUR 1 M (USD 1.25 M) in First Investment Round for MaaT Pharma

09 January 2015
Polyphor develops the elastase inhibitor POL6014 for rare lung diseases using PARI Pharma’s eFlow® Technology inhalation device

08 January 2015
Clinical Network Services (CNS) Establishes US Operations

08 January 2015
MerLion’s finafloxacin shows positive phase 2 results in complicated urinary tract infections

07 January 2015
NetScientific teams up with KU Leuven on research programmes in early cancer detection, epigenomic analysis and fiber-optics diagnostics

07 January 2015
NetScientific announces investment in DName-iT bringing important improvements to diagnostic Next Generation Sequencing

07 January 2015
Nanobiotix 2014 Review, 2015 Anticipated Milestones and Financial Calendar

05 January 2015
AmpliPhi Provides Shareholder Update